The study, published in the current issue of the Journal of the National Cancer Institute determined that the total cancer burden was highest among people in the 50-59 years age bracket, men who have sex with men, those living 5 or more years with AIDS, and non-Hispanic blacks. But the largest excess burden was among people 15-29 years old.
A new analysis of the excess cancer burden among HIV-infected people in the U.S. provides opportunities to develop cancer control initiatives for this population, researchers say.
"It was already known that HIV-infected people have increased cancer risks, so it was not surprising that excess cancers exist in this population," Hilary A. Robbins, of Johns Hopkins Bloomberg School of Public Health in Baltimore, Maryland, told Reuters Health by e-mail.
"However," she said, "we were impressed by the large number of excess cancers, and the degree to which the composition of cancer types varies across subgroups. Both of these results suggest that cancer control initiatives targeted to HIV-infected people could have a large impact."
Read the complete article on Medscape: http://bit.ly/1zHydno
Real-World Study Reveals Key Insights into DLBCL Treatment Patterns, Outcomes
April 18th 2024A recent study offers valuable insights into the characteristics, treatment patterns, and outcomes of diffuse large B-cell lymphoma (DLBCL) in patients across different lines of therapy, providing a look into the landscape of DLBCL management.
Read More
Overcoming Employment Barriers for Lasting Social Impact: Freedom House 2.0 and Pathways to Work
April 16th 2024To help celebrate and recognize National Minority Health Month, we are bringing you a special month-long podcast series with our Strategic Alliance Partner, UPMC Health Plan. Welcome to our second episode, in which we learn all about Freedom House 2.0 and the Pathways to Work program.
Listen
Gene, Light Therapy Combo Shows Promise Against Prostate Cancer Cells in Proof-of-Concept Study
April 18th 2024In their preclinical model, the researchers found efficacy both in vitro and in vivo by using CRISPR-Cas9 to mimic porphyria and combining the technology with light therapy.
Read More
Making Giant Strides in Maternity Health Through Baby Steps
April 9th 2024To help celebrate and recognize National Minority Health Month, we are kicking off a special month-long podcast series with our strategic alliance partner, UPMC Health Plan. Welcome to our first episode, which is all about the Baby Steps Maternity Program and its mission to support women throughout every step of their pregnancy journey.
Listen
Collecting SDOH Data Can Assess Risk of Medical Nonadherence, Improve HEI and Star Ratings
April 18th 2024At the Academy of Managed Care Pharmacy (AMCP) 2024 annual meeting, a panel of presenters explored changes coming to Medicare that incorporate social determinants of health (SDOH) data to improve patient and health system outcomes.
Read More